Evaluation of Human Esophageal Epithelium Permeability in Presence of Different Formulations Containing Hyaluronic Acid and Chondroitin Sulphate

PURPOSE: New medical devices that contain hyaluronic acid (HA) and chondroitin sulphate (CS), with or without antacid components, have been developed for the treatment of gastroesophageal reflux disease (GERD) with the aim of improving oesophageal mucosal defences by creating a film on the oesophage...

Descripción completa

Detalles Bibliográficos
Autores principales: Pellegatta, Gaia, Spadaccini, Marco, Lamonaca, Laura, Craviotto, Vincenzo, D’Amico, Ferdinando, Ceriotti, Laura, Meloni, Marisa, Repici, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069498/
https://www.ncbi.nlm.nih.gov/pubmed/32210642
http://dx.doi.org/10.2147/MDER.S234810

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069498/
https://www.ncbi.nlm.nih.gov/pubmed/32210642
http://dx.doi.org/10.2147/MDER.S234810

Ejemplares similares